levofloxacin has been researched along with Prostatitis in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (1.79) | 18.2507 |
2000's | 24 (42.86) | 29.6817 |
2010's | 28 (50.00) | 24.3611 |
2020's | 3 (5.36) | 2.80 |
Authors | Studies |
---|---|
Gong, WT; He, Q; Qin, Y; Song, NH; Tang, LL; Yang, M; Ye, HS; Zhang, W | 1 |
Gudima, IA; Ibishev, KS; Ismailov, RS; Kogan, MI; Naboka, YL | 1 |
Chen, JQ; Cheng, JL; Liao, XH; Wang, F; Wu, JT | 1 |
Arcaniolo, D; Calace, FP; Creta, M; Crocetto, F; De Sio, M; Fusco, F; Giordano, D; Manfredi, C; Quattrone, C | 1 |
Chen, G; Chen, H; Chen, J; Li, T; Ouyang, L; Wang, X; Xiang, J; Zhang, S | 1 |
Chang, DG; Dai, XH; Guo, Y; Li, J; Wang, X; Wang, Y; Xiong, W; Yany, XZ; Zhang, PH | 1 |
Luo, SB; Meng, ZC; Zhang, JY; Zhang, XY | 1 |
Cai, HC; Cai, WW; Fan, M; Mo, DS; Shang, XJ; Wang, WP; Zhang, GW | 1 |
Aoyama, S; Izumi, K; Miyagi, T; Mizokami, A; Nakagawa, R; Nakashima, T; Ofude, M; Shigehara, K; Urata, S | 1 |
Cai, T; Magri, V; Montanari, E; Perletti, G; Stamatiou, K; Trinchieri, A | 1 |
Bratchikov, OI; Dubonos, PA; Tyuzikov, IA | 1 |
Hannah, JA; Lazaridis, C; Madey, JJ | 1 |
Popov, SV | 1 |
Ales, V; Bertozzi, MA; Dinelli, N; Marzano, R | 1 |
Castiglione, R; Mazzarino, MC; Salemi, M; Vicari, BO; Vicari, E; Vicari, LO | 1 |
Liang, K; Wang, J; Xu, Z; Yan, D | 1 |
Jerončić, A; Papeš, D; Pasini, M | 1 |
Bartoletti, R; Cai, T; Gallelli, L; Malossini, G; Mirone, V; Palmieri, A; Tiscione, D; Verze, P | 1 |
Andryukhin, MI; Mazina, SE; Nikolaev, AL; Talberg, PI | 1 |
Botto, H; Naber, KG; Roscher, K; Schaefer, V | 1 |
Hou, Y; Lü, C; Wu, ZP; Xiao, N; Yang, MG; Zhao, XK | 1 |
Arakawa, S; Fujisawa, M; Shigemura, K; Yamashita, M; Yasufuku, T | 1 |
Fisher, AC; Kahn, JB; Nicholson, SC; Paglia, M; Peterson, J; Qin, Z | 1 |
Mirone, V | 1 |
Garlaschi, MC; Magri, V; Markotić, A; Marras, E; Perletti, G; Restelli, A; Skerk, V | 1 |
Naber, KG; Roscher, K; Wagenlehner, F | 1 |
Bartoletti, R; Boddi, V; Cai, T; Malossini, G; Mazzoli, S; Meacci, F; Mondaini, N | 1 |
Kalfakis, N; Karadima, G; Panas, M; Vassilopoulos, D | 1 |
Baba, S; Fujita, T; Iwamura, M; Kimura, M; Kurosaka, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
Abdelhamid, M; Emran, A; Kamal, A; Mosharafa, A; Torky, M | 1 |
Guo, YL; Jin, FS; Liu, DM; Shen, ZJ; Sun, YH; Zhang, ZC | 1 |
Bellanca, S; Calogero, AE; Condorelli, RA; La Vignera, S; Salmeri, M; Vicari, E | 1 |
Kurnosova, NV; Kuz'menko, AV; Kuz'menko, VV | 1 |
Chao, WF; Huang, XK; Liang, P; Liu, JW; Wang, L; Wang, QT; Yang, H; Yang, W; Zhou, P | 1 |
He, HX; He, Y; Qin, GD; Xiao, MZ; Yang, J; Zeng, Y; Zhou, YD | 1 |
Shen, M; Zhao, Y; Zhou, LQ | 1 |
Cho, YH; Choi, YJ; Hwang, TK; Kim, JC; Lee, SJ; Seo, SI; SW, SW | 1 |
Chai, SE; Choi, HY; Hyun, JH; Jeon, SS; Woo, SH | 1 |
Bundrick, W; Heron, SP; Kahn, JB; Ray, P; Schiff, WM; Tennenberg, AM; Wiesinger, BA; Wright, PA; Wu, SC; Zadeikis, N | 1 |
Barkin, J; Brock, G; Casey, RW; Clark, J; Downey, J; Flax, S; Goldfarb, B; Nickel, JC; Palmer, BW; Patrick, AB; Pommerville, PJ; Steinhoff, G; Zadra, J | 1 |
Naber, KG | 1 |
Bollito, E; Cracco, C; Guercio, S; Poggio, M; Scarpa, RM; Tarabuzzi, R; Terrone, C | 1 |
Kahn, JB; Schaeffer, AJ; Tennenberg, AM; Wu, SC | 1 |
Artemenko, N; Gorelov, A; Perekalina, T; Smelov, V; Smelova, N; Ukleeva, G | 1 |
Byrns, K; Goldner, B; Makaryus, AN; Makaryus, MN; Natarajan, U; Singer, C | 1 |
Adebayo, SA; Olapade-Olaopa, EO | 1 |
Cai, X; Huang, YF; Shang, XJ; Teng, WH; Xu, H | 1 |
Barbone, F; De Maria, M; Giannarini, G; Manassero, F; Mogorovich, A; Morelli, G; Selli, C; Valent, F | 1 |
Nickel, JC; Xiang, J | 1 |
Miyagi, T; Nakashima, T; Shigehara, K; Shimamura, M | 1 |
Guo, DF; Wang, HP; Zhang, HZ | 1 |
Jeong, CW; Jeong, H; Lee, SE; Lim, DJ; Son, H | 1 |
Ishitoya, S; Kamoto, T; Ogawa, O; Okumura, K; Segawa, T; Yamamoto, S | 1 |
Boccumini, L; Corrado, M; Drusano, GL; Gombert, M; Kahn, J; North, D; Oefelein, M; Preston, SL; Van Guilder, M; Weisinger, B | 1 |
Trinchiere, A | 1 |
Horiba, M; Suzuki, K | 1 |
4 review(s) available for levofloxacin and Prostatitis
Article | Year |
---|---|
[Rational antimicrobial therapy of chronic bacterial prostatitis].
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Staphylococcal Infections; Staphylococcus; Treatment Outcome | 2013 |
[From cystitis to bacterial prostatitis: experience with levofloxacin].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cystitis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Multicenter Studies as Topic; Ofloxacin; Practice Guidelines as Topic; Prostatitis; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Urethritis; Urinary Tract Infections | 2009 |
Levofloxacin in the treatment of urinary tract infections and prostatitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostatitis; Quinolones; Severity of Illness Index; Treatment Outcome; Urinary Tract Infections | 2004 |
[Role of levofloxacin in the treatment of urinary tract infections].
Topics: Anti-Infective Agents, Urinary; Female; Humans; Levofloxacin; Male; Ofloxacin; Prostatitis; Urinary Tract Infections | 2001 |
23 trial(s) available for levofloxacin and Prostatitis
Article | Year |
---|---|
[Linshu Decoction combined with levofloxacin for lower urinary tract symptoms in patients with type ⅢA prostatitis].
Topics: Chronic Disease; Humans; Levofloxacin; Lower Urinary Tract Symptoms; Male; Medicine, Chinese Traditional; Prostatitis | 2020 |
[Extended culture study as a keypoint to rethinking antibiotic therapy for chronic bacterial prostatitis].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Humans; Levofloxacin; Male; Prostatitis | 2023 |
[Medication versus health education for patients with type Ⅲ prostatitis-like symptoms: A prospective randomized control study].
Topics: Adrenergic alpha-1 Receptor Antagonists; Chronic Disease; Humans; Levofloxacin; Male; Patient Education as Topic; Prospective Studies; Prostatitis; Quality of Life; Tamsulosin; United States; Urological Agents | 2019 |
Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Escherichia coli; Humans; Levofloxacin; Male; Middle Aged; Prostatitis; Treatment Outcome; Young Adult | 2021 |
[Acupuncture combined with western medicine for CP/CPPS:a randomized controlled trial].
Topics: Acupuncture Points; Acupuncture Therapy; Chronic Disease; Chronic Pain; Combined Modality Therapy; Humans; Levofloxacin; Male; Pelvic Pain; Prostatitis; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2016 |
[Traditional Chinese medicine fumigation combined with Levofloxacin for type ⅢA prostatitis with the symptoms of damp heat and blood stasis].
Topics: Anti-Bacterial Agents; Chronic Disease; Drugs, Chinese Herbal; Fumigation; Hot Temperature; Humans; Levofloxacin; Male; Medicine, Chinese Traditional; Prostatitis; Severity of Illness Index; Symptom Assessment | 2017 |
[Triple acupuncture at the Qugu acupoint as an adjunctive therapy for type-Ⅲ chronic prostatitis: Analysis of short- and long-term clinical effects].
Topics: Acupuncture Points; Acupuncture Therapy; Anti-Bacterial Agents; Chronic Disease; Chronic Pain; Combined Modality Therapy; Drug Therapy, Combination; Humans; Levofloxacin; Male; Pelvic Pain; Prazosin; Prostatitis; Quality of Life; Recurrence; Syndrome; United States; Urological Agents | 2017 |
A randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Chronic Disease; Drug Therapy, Combination; Humans; Levofloxacin; Male; Pelvic Pain; Prazosin; Prospective Studies; Prostatitis; Syndrome; Treatment Outcome; Urological Agents | 2016 |
Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
Topics: Adult; Anti-Bacterial Agents; Bromelains; Carotenoids; Chronic Disease; Dimethyl Sulfoxide; Drug Therapy, Combination; Follow-Up Studies; Humans; Levofloxacin; Lycopene; Male; Plant Extracts; Prospective Studies; Prostatitis; Selenium; Serenoa; Sulfones; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2016 |
Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2008 |
[Corticoid combined with an antibiotic for chronic nonbacterial prostatitis].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Glucocorticoids; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prednisone; Prostatitis; Treatment Outcome; Young Adult | 2009 |
Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2010 |
Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients.
Topics: Adult; Anti-Bacterial Agents; Asian People; Ciprofloxacin; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome | 2012 |
[Efficacy of compound Xuanju capsule in the treatment of chronic prostatitis with erectile dysfunction].
Topics: Adult; Capsules; Chronic Disease; Drugs, Chinese Herbal; Erectile Dysfunction; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Phytotherapy; Prazosin; Prostatitis; Treatment Outcome; Young Adult | 2012 |
Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2003 |
Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.
Topics: Adult; Aged; Anti-Infective Agents; Chronic Disease; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pelvic Pain; Pilot Projects; Prostatitis; Safety; Treatment Outcome | 2003 |
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2005 |
[Longqingpian combined with levofloxacin highly effective for type IIIA prostatitis].
Topics: Adult; Chronic Disease; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Phytotherapy; Prostatitis | 2007 |
Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Dioxolanes; Double-Blind Method; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Piperazines; Prospective Studies; Prostatitis; Quinolones | 2007 |
[Yiqigushen capsule combined with levofloxacin highly effective for type III A prostatitis].
Topics: Adult; Anti-Infective Agents, Urinary; Capsules; Chronic Disease; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Levofloxacin; Male; Medicine, Chinese Traditional; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2008 |
Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Bacterial Agents; Doxazosin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis | 2008 |
Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Cystitis; Fluoroquinolones; Humans; Levofloxacin; Male; Naphthyridines; Ofloxacin; Prospective Studies; Prostate; Prostatitis; Rectum | 2008 |
A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Demography; Humans; Levofloxacin; Male; Middle Aged; Monte Carlo Method; Ofloxacin; Prostate; Prostatitis | 2000 |
29 other study(ies) available for levofloxacin and Prostatitis
Article | Year |
---|---|
[Fosfomycin tromethamine inhibits the expressions of TNF-α, IL-8 and IL-6 in the prostate tissue of rats with chronic bacterial prostatitis].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Fosfomycin; Interleukin-6; Interleukin-8; Levofloxacin; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2018 |
Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Aged; Antibiotic Prophylaxis; Bacteria; Biopsy, Large-Core Needle; Drug Therapy, Combination; Gentamicins; Humans; Incidence; Levofloxacin; Male; Postoperative Complications; Prostate; Prostatic Neoplasms; Prostatitis; Rectum; Retrospective Studies; Ultrasonography, Interventional | 2019 |
Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
Topics: Adult; Aged; Anti-Bacterial Agents; Azithromycin; Candida albicans; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; National Institutes of Health (U.S.); Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Treatment Outcome; United States; Young Adult | 2019 |
[Justification of a use of additional antioxidant therapy in experimental models of chronic bacterial prostatitis].
Topics: Adult; Animals; Anti-Bacterial Agents; Antioxidants; Bacterial Infections; Disease Models, Animal; Humans; Levofloxacin; Lipid Peroxidation; Male; Oxidative Stress; Prostatitis; Rats; Superoxide Dismutase | 2019 |
Central pontine myelinolysis following acute hypoglycemia.
Topics: Acute Disease; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Diffusion Magnetic Resonance Imaging; Humans; Hypoglycemia; Kidney Diseases; Levofloxacin; Magnetic Resonance Imaging; Male; Middle Aged; Myelinolysis, Central Pontine; Neurologic Examination; Pancreatitis; Prostatitis; Quadriplegia; Tomography, X-Ray Computed | 2013 |
Effectiveness on urinary symptoms and erectile function of Prostamev Plus® vs only extract Serenoa repens.
Topics: Adult; Aged; Anti-Bacterial Agents; Bromelains; Humans; Jatropha; Levofloxacin; Male; Middle Aged; Phytotherapy; Plant Extracts; Prostatitis; Quality of Life; Serenoa; Treatment Outcome; Ultrasonography; Urination; Urtica dioica | 2015 |
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chlamydia; Chronic Disease; Humans; Infertility, Male; Interleukin-6; Italy; Leukocyte Count; Levofloxacin; Male; Prostatitis; Reactive Oxygen Species; Semen; Sperm Motility; Treatment Outcome; Tumor Necrosis Factor-alpha; Viscosity; Young Adult | 2016 |
Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/
Topics: Humans; Levofloxacin; Male; Pelvic Pain; Prazosin; Prostatitis | 2017 |
[Ultrasound physiotherapy treatment of prostatitis].
Topics: Animals; Anti-Bacterial Agents; Bacteria; Chronic Disease; Humans; Immunomodulation; Levofloxacin; Male; Physical Therapy Modalities; Prostatitis; Rats; Rats, Wistar; Time Factors; Tissue Distribution; Ultrasonic Therapy | 2016 |
Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Male; Ofloxacin; Prostate; Prostatitis; Rectum; Retrospective Studies; Risk Factors; Ultrasound, High-Intensity Focused, Transrectal | 2009 |
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Drug Therapy, Combination; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis; Semen; Urethra | 2010 |
[Practice management of chronic bacterial prostatitis with levofloxacin].
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Chronic Disease; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis; Recurrence; Staphylococcal Infections | 2011 |
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Prostatitis; Young Adult | 2011 |
Hereditary neuropathy unmasked by levofloxacin.
Topics: Anti-Bacterial Agents; Charcot-Marie-Tooth Disease; Diagnosis, Differential; Family Health; Humans; Hypesthesia; Levofloxacin; Male; Middle Aged; Mobility Limitation; Muscle Weakness; Ofloxacin; Pain; Prostatitis; Severity of Illness Index | 2011 |
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Ofloxacin; Prevalence; Prostate; Prostatitis; Rectum | 2011 |
Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions?
Topics: Aged; Anti-Bacterial Agents; Asymptomatic Diseases; Biopsy; Diagnostic Errors; Drug Administration Schedule; Egypt; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Predictive Value of Tests; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Sensitivity and Specificity; Time Factors; Treatment Outcome; Up-Regulation | 2011 |
Persistence of ultrasound alterations after antibiotic treatment with levofloxacin in patients with male accessory gland infection.
Topics: Adult; Anti-Bacterial Agents; Epididymis; Epididymitis; Genital Diseases, Male; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Retrospective Studies; Seminal Vesicles; Superinfection; Ultrasonography | 2012 |
[Correction of psychoemotional status in patients with chronic bacterial prostatitis].
Topics: Adult; Anti-Anxiety Agents; Anti-Infective Agents, Urinary; Biureas; Drug Therapy, Combination; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2012 |
Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Anti-Bacterial Agents; Drug Interactions; Escherichia coli Infections; Kidney; Levofloxacin; Liver; Male; Ofloxacin; Prostate; Prostatitis; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin | 2013 |
[Detection of bacterial 16S rRAN gene in EPS of men with chronic pelvic pain syndrome and its clinical significance].
Topics: Anti-Bacterial Agents; Azithromycin; Chronic Disease; Humans; Levofloxacin; Male; Ofloxacin; Pelvic Pain; Polymerase Chain Reaction; Prostatitis; RNA, Bacterial; RNA, Ribosomal, 16S | 2003 |
Effects of androgen deprivation on chronic bacterial prostatitis in a rat model.
Topics: Androgen Antagonists; Animals; Anti-Infective Agents, Urinary; Castration; Chronic Disease; Enzyme Inhibitors; Escherichia coli Infections; Estradiol; Estrogens; Finasteride; Levofloxacin; Male; Models, Animal; Ofloxacin; Prostatitis; Random Allocation; Rats; Rats, Wistar; Testosterone | 2003 |
Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
Topics: Adenocarcinoma; Administration, Oral; Administration, Rectal; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacterial Infections; Biomarkers, Tumor; Biopsy, Needle; Bisacodyl; Cefixime; Epididymitis; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Retrospective Studies; Risk Factors; Ultrasonography, Interventional | 2003 |
PSA decrease after levofloxacin therapy in patients with histological prostatitis.
Topics: Aged; Anti-Bacterial Agents; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis; Retrospective Studies | 2004 |
Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Chronic Disease; Fluoroquinolones; Humans; Levofloxacin; Male; Ofloxacin; Prostatitis; Quinolones | 2005 |
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Levofloxacin; Long QT Syndrome; Male; Ofloxacin; Prognosis; Prospective Studies; Prostatitis; Respiratory Tract Infections; Severity of Illness Index; Urinary Tract Infections | 2006 |
Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Levofloxacin; Male; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2006 |
Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis | 2008 |
Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis.
Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Blood; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostate; Prostatitis; Ultrasound, High-Intensity Focused, Transrectal; Urinary Tract Infections; Urine | 2008 |
[Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis].
Topics: Adult; Aged; Chronic Disease; Drug Administration Schedule; Epididymitis; Escherichia coli; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Staphylococcus; Urinary Tract Infections | 1992 |